Skip to main content
Equibles

Legal & General Group Plc

Position in ARDX — Ardelyx, Inc.

CIK 764068 London, X0
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$996,865
-$241,039 QoQ
Shares Held
195,464
-5.4% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 250 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. ARDX ranks #112 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in ARDX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $996,865 195,464
2026-03-31 $1,237,904 206,662
2025-12-31 $1,563,972 268,263
2025-09-30 $1,482,965 269,141
2025-06-30 $1,079,347 275,344
2025-03-31 $1,191,194 242,606
2024-12-31 $1,234,194 243,431
2024-09-30 $1,648,941 239,324
2024-06-30 $1,769,499 238,799
2024-03-31 $1,714,294 234,835
2023-12-31 $1,365,469 220,237
2023-09-30 $807,088 197,816
2023-06-30 $676,660 199,605
2023-03-31 $255,043 53,245
2022-03-31 $8,935 8,351
2021-12-31 $9,186 8,351
2021-09-30 $135,827 102,900
2021-06-30 $82,037 10,823
2021-03-31 $73,315 11,075
2020-12-31 $74,326 11,488
2020-09-30 $60,312 11,488
2020-06-30 $100,588 14,536
2020-03-31 $44,365 7,804